Showing results (251-260 of 405) with videos related to
Sort By:
Pageof 41
JCI Insight|January 25, 2019
HDAC9 complex inhibition improves smooth muscle-dependent stenotic vascular diseaseChristian L Lino Cardenas, Chase W Kessinger, Elizabeth Chou, et al.JAMA Network Open|February 25, 2021
Pharmacologic Interventions for Breathlessness in Patients With Advanced Cancer: A Systematic Review and Meta-analysisJosephine L Feliciano, Julie M Waldfogel, Ritu Sharma, et al.American Journal of Clinical Oncology|January 13, 2017
Impact of Concurrent Medication Use on Pancreatic Cancer Survival-SEER-Medicare AnalysisMuhammad S Beg, Arjun Gupta, David Sher, et al.Journal of Geriatric Oncology|June 28, 2025
Oncologist perspectives on the acceptability, appropriateness, and feasibility of the Cancer and Aging Research Group (CARG) chemotherapy toxicity prediction tool for older adultsWhitney V Johnson, Arjun Gupta, Anne H Blaes, et al.Frontiers in Oncology|October 13, 2025
Time and cost burden associated with docetaxel in patients with metastatic castration-sensitive prostate cancer initiating an androgen receptor pathway inhibitor-based regimenDaniel Sentana-Lledo, Arjun Gupta, Carmine Rossi, et al.JB & JS Open Access|January 26, 2023
Effect of Faculty Diversity on Minority Student Populations Matching into Orthopaedic Surgery Residency ProgramsKenneth H Levy, Arjun Gupta, Christopher J Murdock, et al.Lung Cancer (Amsterdam, Netherlands)|December 19, 2016
Premorbid body mass index and mortality in patients with lung cancer: A systematic review and meta-analysisArjun Gupta, Kaustav Majumder, Nivedita Arora, et al.Journal of Cancer Policy|July 23, 2025
Comparing the time spent in clinic by patients receiving, subcutaneous and intravenous formulations of cancer drugs: A pilot studySana Kagalwalla, Alexander K Tsai, Michelle Tregear, et al.Heart Rhythm|March 20, 2010
Impact of segmental left ventricle lead position on cardiac resynchronization therapy outcomesFaisal M Merchant, E Kevin Heist, David McCarty, et al.European Heart Journal|October 3, 2009
Abnormal myocardial insulin signalling in type 2 diabetes and left-ventricular dysfunctionStuart A Cook, Anabel Varela-Carver, Marco Mongillo, et al.Pageof 41